A Comprehensive Review of MR Imaging Changes following Radiosurgery to 500 Brain Metastases
Authors:
- B.J. McHughBMB.J. McHugh
- W.L. BiWBW.L. Bi
- F.J. MinjaFMF.J. Minja
- J.P.S. KniselyJKJ.P.S. Knisely
- V.L. ChiangVCV.L. Chiang
Open Access
- 15 September 2011
- journal article
- review article
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 32 (10) , 1885-1892
Abstract
Stereotactic radiosurgery is known to control 85%-95% of intracranial metastatic lesions during a median survival of 6-8 months. However, with the advent of newer systemic cancer therapies, survival is improving; this change mandates a longitudinal quantitative analysis of the radiographic response of brain metastases to radiosurgery. MR imaging of 516 metastases in 120 patients treated with GK-SRS from June 2006 to December 2009 was retrospectively reviewed. Lesion volume at initial treatment and each follow-up was calculated by using the following formula: length × width × height / 2. Volume changes were correlated with patient demographics, histopathology, and radiation treatment variables. Thirty-two percent of lesions increased in volume following radiosurgery. Clinically, this translated into 54% of patients having ≥1 of their lesions increase in size. This increase begins at 6 weeks and can last beyond 15 months' post-SRS. Male sex (P = .002), mean voxel dose 500 mm(3) (P < .001) are associated with posttreatment increases in tumor size. Median survival following radiosurgery was 9.5 months for patients with all lesions exhibiting stable/decreased volumes, >18.4 months for patients with all lesions exhibiting increased volumes, and 16.4 months for patients with mixed lesional responses. Most metastatic lesions are stable or smaller in size during the first 36 months post-SRS. However, a transient increase in volume is seen in approximately one-third of lesions. Sex, treatment dose, initial lesion size, and histopathology all correlate with variations in lesion volume post-SRS. The longer the patient survives, the more likely an increase in lesion size will be seen on follow-up imaging.Keywords
This publication has 21 references indexed in Scilit:
- Stereotactic Radiosurgery for the Management of Brain MetastasesNew England Journal of Medicine, 2010
- Gamma Knife surgery for brain metastases from gastrointestinal cancerJournal of Neurosurgery, 2009
- Stereotactic radiosurgery for the treatment of brain metastasesRadiotherapy and Oncology, 2009
- Early brain tumor metastasis reduction following Gamma Knife surgeryJournal of Neurosurgery, 2009
- Brain metastases: current management and new developmentsCurrent Opinion in Oncology, 2008
- Gamma Knife surgery for metastatic brain tumors from renal cell carcinomaJournal of Neurosurgery, 2006
- Gamma knife surgery for brain metastases from lung cancerJournal of Neurosurgery, 2005
- Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- MR Imaging Response of Brain Metastases after Gamma Knife Stereotactic RadiosurgeryRadiology, 1999
- Serial MR imaging of intracranial metastases after radiosurgeryMagnetic Resonance Imaging, 1997